Skip to content
10-Q/A

Quarterly Report

VAPORIN, INC.

0001493152-14-003624

← back to feed
Filed
Nov 12, 2014 12:00 AM ET
Period of report
Amendment. Amends a previously filed report.
Restated figures. One or more values in this filing restate previously reported amounts.

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q3 2014 · Oct 27, 2014 4.78M sh
Cash And Equivalents Q3 2014 · Sep 30, 2014 $769.52K
Cash And Equivalents Q3 2014 · Dec 31, 2013 $25.22K
Cash And Equivalents restated Q3 2014 · Sep 30, 2013 $815
Stockholders Equity Q3 2014 · Sep 30, 2014 $5.67M
Stockholders Equity Q3 2014 · Dec 31, 2013 $43.18K
Total Liabilities Q3 2014 · Sep 30, 2014 $739.38K
Total Liabilities Q3 2014 · Dec 31, 2013 $368.02K
Current Assets Q3 2014 · Sep 30, 2014 $2.57M
Current Assets Q3 2014 · Dec 31, 2013 $390.53K
Total Assets Q3 2014 · Sep 30, 2014 $6.41M
Total Assets Q3 2014 · Dec 31, 2013 $411.2K
Sga Expense Q3 2014 · Sep 30, 2014 $1.6M
Sga Expense restated Q3 2014 · Sep 30, 2013 $35.95K
Net Income Q3 2014 · Sep 30, 2014 −$1.36M
Net Income restated Q3 2014 · Sep 30, 2013 −$48.48K
Operating Income Q3 2014 · Sep 30, 2014 −$1.39M
Operating Income restated Q3 2014 · Sep 30, 2013 −$48.48K
Gross Profit Q3 2014 · Sep 30, 2014 $413K
Gross Profit Q3 2014 · Sep 30, 2013 −$12.53K
Cost Of Revenue Q3 2014 · Sep 30, 2014 $424.21K
Cost Of Revenue Q3 2014 · Sep 30, 2013 $40.99K
Revenue Q3 2014 · Sep 30, 2014 $837.21K
Revenue Q3 2014 · Sep 30, 2013 $28.46K